Dr. Bamji, the COVID‑19 vaccine race made us realize that basic research is essential to enable innovation and that the exploratory part of the research feeds into the applied research, as it is the tip of the iceberg that we see more of. In short, messenger RNA vaccines are, after all, the result of basic work that began in the late 1970s and has never stopped since.
Given the importance of basic research, do you consider the latest investments proposed by the government to be sufficient, given that they have been greatly reduced over the past 10 years?